EmaxHealth

Health knowledge and news provided by doctors.

Ads by Google

Diabetes Care

People who have diabetes, whether it is the most common type 2 diabetes, type 1 diabetes, or gestational diabetes, need current, well-researched information on all aspects of the disease. Emaxhealth has expert reporters who provide articles on the latest research as well as important lifestyle guidelines regarding all forms of diabetes.

Which Plant-Based Diet Reduces Diabetes Risk?

plant based diet and diabetes

Numerous studies have noted that people who follow a vegetarian diet have a lower risk of various health problems, including but not limited to overweight and obesity, some cancers, cataracts, diverticular disease, and diabetes. When it comes to diabetes, a new study focused on which type of plant-based diet reduces diabetes risk, as it appears not all such diets lower the risk equally.

New Treatment for Diabetes By Reprogramming Cells

Diabetes treatment and human cell

Scientists at the Gladstone Institutes, and the University of California, San Francisco (UCSF) have succeeded in transforming human fibroblasts, a type of skin cell, into pancreatic cells via a process called direct cellular reprogramming, an accomplishment that brings personalized cell therapy one step closer for those who suffer from diabetes.

New type of immunotherapy could be game changer for type 1 diabetes

Treg therapy could stop type 1 diabetes

University of California San Francisco scientists and physicians have conducted a promising first study that could be a game changer for treating type 1 diabetes. The disease affects approximately 1.26 American children and adults according to the American Diabetes Association. The therapy acts by suppressing the body's immune system that attacks insulin producing beta cells in the pancreas.

Huge Tehran Research Shows Vitamin C Found to Lower Blood Sugar in Type 2 Diabetes

Vitamin C and lowering blood Sugar

A new study in the Journal of Pharmacy and Pharmaceutical Science has found taking vitamin C helps lower fasting blood sugar in type 2 diabetes mellitus (T2DM) by an average of 21mg/dl, although it did not have a definitive effect on glycated hemoglobin (HbA1c). The research included 38 articles; 26 observational studies and 12 random controlled trials (RCTs).

New Cell Therapy Product Closer to Reality for Type 1 Diabetics

Viacyte

A new potentially life-changing device for people with Type 1 diabetes mellitus (T1DM) is one step closer to being available for general use on patients. The device, which is the size of a Band-Aid, is made by ViaCyte, Inc. and delivers human progenitor stem cells designed to regenerate pancreatic cells that produce insulin. ViaCyte is headquartered in San Diego, California with additional operations in Athens, Georgia and is funded in part by the California Institute for Regenerative Medicine (CIRM) and the Juvenile Diabetes Research Foundation (JDRF).

Sanofi's inhalable insulin Afrezza new hope for diabetes treatment

Afrezza for diabetes treatment

Early in 2015, it was announced that the world’s first viable, inhalable form of insulin, Afrezza, was about to hit the market. Another similar drug, Exubera, marketed by Pfizer in 2005, failed in marketplace showing as well as efficacy due to the enormous size of the delivery device, and was taken off the market within two years.

Pages